(Q34249681)

English

Acquired Factor VIII autoantibody: four cases demonstrating the heterogenous nature of this condition and problems involved in diagnosis and treatment

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Acquired Factor VIII autoantibody: four cases demonstrating the heterogenous nature of this condition and problems involved in diagnosis and treatment (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

based on heuristic

inferred from title

author name string

Hall RL

1

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Leahy MF

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

publication date

1 March 2001

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

European Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

66

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

206-209

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Acquired hemophilia due to factor VIII inhibitors in 34 patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00383.X

21 January 2018

Inhibitors to clotting factors

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00383.X

21 January 2018

Autoimmune factor VIII inhibitors

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00383.X

21 January 2018

PARTIAL THROMBOPLASTIN TIME TEST WITH KAOLIN. NORMAL RANGE AND MODIFICATIONS FOR THE DIAGNOSIS OF HAEMOPHILIA AND CHRISTMAS DISEASE.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00383.X

21 January 2018

Severe aquired haemophilia A treated with recombinant factor VIIa

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00383.X

21 January 2018

Severe acquired hemophilia A successfully treated with activated recombinant human factor VII.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00383.X

21 January 2018

Cross-reactivity to porcine factor VIII of factor VIII inhibitors in patients with haemophilia in Australia and New Zealand

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00383.X

21 January 2018

Acquired factor VIII inhibitors--successful treatment with an oral outpatient regimen

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00383.X

21 January 2018

Successful treatment of acquired hemophilia with oral immunosuppressive therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00383.X

21 January 2018

Successful treatment of acquired factor VIII inhibitors with cyclosporin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2001.00383.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1034/J.1600-0609.2001.00383.X

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34249681&oldid=1603259168"